First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Down 65.6% in March

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 17,467 shares, a decrease of 65.6% from the February 26th total of 50,788 shares. Based on an average daily trading volume, of 74,513 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.7% of the company’s shares are short sold. Currently, 1.7% of the company’s shares are short sold. Based on an average daily trading volume, of 74,513 shares, the days-to-cover ratio is presently 0.2 days.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

FBT opened at $191.75 on Wednesday. First Trust NYSE Arca Biotechnology Index Fund has a 12 month low of $141.38 and a 12 month high of $224.94. The business has a 50-day moving average of $207.03 and a two-hundred day moving average of $200.67. The stock has a market capitalization of $201.34 million, a price-to-earnings ratio of 21.72 and a beta of 0.65.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several institutional investors have recently made changes to their positions in FBT. Financial Enhancement Group LLC raised its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 2.9% during the 3rd quarter. Financial Enhancement Group LLC now owns 5,820 shares of the company’s stock valued at $1,093,000 after buying an additional 162 shares during the period. HF Advisory Group LLC grew its position in First Trust NYSE Arca Biotechnology Index Fund by 7.8% in the third quarter. HF Advisory Group LLC now owns 1,375 shares of the company’s stock valued at $247,000 after acquiring an additional 99 shares in the last quarter. Dominguez Wealth Management Solutions Inc. purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the third quarter valued at approximately $210,000. Forefront Wealth Partners LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the second quarter valued at approximately $507,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the second quarter worth $1,537,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.